References

Abramovici A, Josefsberg Z, Mimouni M, Liban E, Laron Z 1983 Histopathological features of the skin in hypopituitarism and Laron-type dwarfism. Isr J Med Sci 19:515—519 Amselem S, Sobrier ML, Dastot F, Duquesnoy P, Duriez B, Goossens M 1996 Molecular basis of inherited growth hormone resistance in childhood. Bailliere's Clin Endocrinol Metab 10:353—369

Arvat E, Broglio F, Ghigo E 2000 Insulin-like growth factor I: implications in aging. Drugs Aging 16:29—40

Bartke A 1998 Growth hormone and aging. Endocrine 8:103—108

Bartke A 2000 Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size. In: Hekimi (ed) The molecular genetics of aging. Results and problems in cell differentiation. Springer-Verlag, Berlin, vol 26:181—202 Brat O, Ziv I, Klinger B, Avraham M, Laron Z 1997 Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome. Horm Res 47:45—48 Butterfield GE, Thompson J, Rennie MJ, Marcus R, Hintz RL, Hoffman AR 1997 Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women. Am J Physiol 272:E94—E99

Carroll PV, Christ ER, Bengtsson BA et al 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395 Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ 2000 Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608-2613 Galatzer A, Aran O, Nagelberg N, Rubitzek J, Laron Z 1993 Cognitive and psychosocial functioning of young adults with Laron syndrome. In: Laron Z, Parks JS (eds) Pediatric and adolescent endocrinology, vol 24: Lessons from Laron syndrome (LS) 1966-1992. Karger, Basel, p 53-60

Gil-Ad I, Gurewitz R, Marcovici O, Rosenfeld J, Laron Z 1984 Effect of aging on human plasma growth hormone response to clonidine. Mech Ageing Dev 27:97-100 Godowski PJ, Leung DW, Meacham LR et al 1989 Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:8083-8087 Groesbeck MD, Parlow AF, Daughaday WH 1987 Stimulation of supranormal growth in prepubertal adult plateaued and hypophysectomized female rats by large doses of rat growth hormone: physiological effects and adverse consequences. Endocrinology 120:1963-1975 Hanhart E 1925 Uber heredodegenerativen Zwergwuchs mit Dystrophia adiposo-genitalis.

Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg 1:235-253 Kaufmann S, Jones M, Culler FL, Jones KL 1986 Growth hormone deficiency in the

Rothmund-Thomson syndrome. Am J Med Genet 23:861-868 Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G 1997 daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditiselegans. Science 277:942-946 Kopchick JJ, Laron Z 1999 Is the Laron mouse an accurate model of Laron syndrome? Mol

Genet Metab 68:232-236 Krzisnik C, Kolacio Z, Battelino T, Brown M, Parks JS, Laron Z 1999 The 'Little People' of the Island of Krk—revisited. Etiology of hypopituitarism revealed. J Endocrine Genet 1:9-19 Laron Z 1999a Laron syndrome: primary growth hormone resistance. In: Jameson JL (ed) Hormone resistance syndromes. Contemporary endocrinology. Humana Press, Clifton, NJ, vol 2:17-37

Laron Z 1999b Natural history of the classical form of primary growth hormone (GH) resistance

(Laron syndrome). J Pediatr Endocrinol Metab 12:231-249 Laron Z 1999c Somatomedin-1 (recombinant insulin-like growth factor-1): clinical pharmacology and potential treatment of endocrine and metabolic disorders. BioDrugs 11:55-70 (erratum: 1999 BioDrugs 11:114) Laron Z 2001 Molecular mutations in the human growth hormone axis. In: Eugster EA, Pescovitz OH (eds) Developmental endocrinology from research to clinical practice. Humana Press, Clifton, NJ Laron Z, Klinger B 1993 Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. Horm Res 40:16-22 Laron Z, Klinger B 1994 IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clin Endocrinol 41:631-638 Laron Z, Parks JS 1993 Pediatric and adolescent endocrinology, vol 24: Lessons from Laron syndrome (LS) 1966-1992. Karger, Basel Laron Z, Pertzelan A, Karp M 1968 Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 4:883-894 Laron Z, Pertzelan A, Karp M, Kowadlo-Silbergeld A, Daughaday WH 1971 Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 33:332-342

Laron Z, Avitzur Y, Klinger B 1997 Insulin resistance in Laron syndrome (primary insulin-like growth factor-I (IGF-I) deficiency) and effect of IGF-I replacement therapy. J Pediatr Endocrinol Metab 10:105-115 Laron Z, Ben-Amitai D, Lurie R 2001 Impaired hair growth and structural defects in patients with Laron syndrome (Primary IGF-I deficiency). Pediat Res 49:76A Li S, Crenshaw BE 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain genepit-I. Nature 347:528-533 Masoro EJ 1992 Retardation of aging processes by nutritional means. Ann NY Acad Sci USA 673:29-35

Merimee T, Laron Z 1996 Modern endocrinology and diabetes, vol 4: Growth hormone, IGF-I

and growth: new views of old concepts. Freund Publishing House Ltd, Tel Aviv Merimee T, Rimoin DL, Hall JD, McKusick VA 1969 A metabolic and hormonal basis for classifying ateliotic dwarfs. Lancet 1:963-965 Nance MA, Berry SA 1992 Cockayne syndrome: review of 140 cases. Am J Med Genet 42:68-84 Pesce K, Rothe MJ 1996 The premature aging syndromes. Clin Dermatol 14:161-170 Rimoin DL, Merimee TJ, McKusick VA 1966 Sexual ateliotic dwarfism: a recessively inherited isolated deficiency of human growth hormone. Trans Assoc Am Physicians 79:297-304 Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288 Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson BA 1993 Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195-200 Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U 1999 Growth hormone receptor deficiency in Ecuador. J Clin Endocrinol Metab 84:4436-4443 Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J 1994 Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 15:369-390 Rubin CD, Reed B 1996 Twenty-four hour growth hormone secretion in a patient with Werner's syndrome. Exp Gerontol 31:557-561 Rudman D, Feller AG, Nagraj HS et al 1990 Effects of human growth hormone in men over 60

years old. N Engl J Med 323:1-6 Schaible R, Gowen JW 1961 A new dwarf mouse. Genetics 46:896

Sornson MW, Wu W, Dasen JS et al 1996 Pituitary lineage determination by the prophet of Pit-1

homeodomain factor defective in Ames dwarfism. Nature 384:327-333 Takala J, Ruokonen E, Webster NR et al 1999 Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785-792 Toogood AA, Shalet SM 1998 Ageing and growth hormone status. Baillieres Clin Endocrinol Metab 12:281-296

van Buul-Offers S, Veda I, van den Brande JL 1986 Biosynthetic somatomedin C (SM-C/IGF-I)

increases the length and weight of Snell dwarf mice. Pediatr Res 20:825-827 Villee DB, Nichols G Jr, Talbot NB 1969 Metabolic studies in two boys with classical progeria. Pediatrics 43:207-216

Zhou Y, Xu BC, Maheshwari HG et al 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220

0 0

Post a comment